163 related articles for article (PubMed ID: 18324478)
1. VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value.
Dirim A; Haberal AN; Goren MR; Tekin MI; Peskircioglu L; Demirhan B; Ozkardes H
Int Urol Nephrol; 2008; 40(4):861-8. PubMed ID: 18324478
[TBL] [Abstract][Full Text] [Related]
2. COX-2 Expression in Renal Cell Carcinoma and Correlations with Tumor Grade, Stage and Patient Prognosis.
Tabriz HM; Mirzaalizadeh M; Gooran S; Niki F; Jabri M
Asian Pac J Cancer Prev; 2016; 17(2):535-8. PubMed ID: 26925639
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
4. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
6. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
Tawfik OW; Kramer B; Shideler B; Danley M; Kimler BF; Holzbeierlein J
Arch Pathol Lab Med; 2007 Feb; 131(2):261-7. PubMed ID: 17284111
[TBL] [Abstract][Full Text] [Related]
9. Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.
Ali S; Yin-Goen Q; Johnson TV; Han W; Johnson NA; Harris WB; Marshall FF; Young AN; Master VA; Osunkoya AO
Tumour Biol; 2011 Apr; 32(2):375-80. PubMed ID: 21086092
[TBL] [Abstract][Full Text] [Related]
10. [Expression of IGF-IR and COX-2 in renal cell carcinoma and their relationship with cell proliferation].
Sun H; Wang H; Qin WJ; Yang B; Wang SC; Jian BL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):348-50. PubMed ID: 19351509
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.
Minardi D; Lucarini G; Mazzucchelli R; Milanese G; Natali D; Galosi AB; Montironi R; Biagini G; Muzzonigro G
J Urol; 2005 Oct; 174(4 Pt 1):1208-12. PubMed ID: 16145371
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
[TBL] [Abstract][Full Text] [Related]
13. VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.
Song SH; Jeong IG; You D; Hong JH; Hong B; Song C; Jung WY; Cho YM; Ahn H; Kim CS
Int J Clin Exp Pathol; 2014; 7(11):7681-9. PubMed ID: 25550804
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma.
Yilmazer D; Han U; Onal B
Int Urol Nephrol; 2007; 39(3):691-8. PubMed ID: 17180739
[TBL] [Abstract][Full Text] [Related]
15. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
Chang BD; Cao LS; Zhou HL
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
[TBL] [Abstract][Full Text] [Related]
16. Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.
Osman WM; Youssef NS
Int J Clin Exp Pathol; 2015; 8(7):8165-77. PubMed ID: 26339385
[TBL] [Abstract][Full Text] [Related]
17. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma.
Morell-Quadreny L; Clar-Blanch F; Fenollosa-Enterna B; Perez-Bacete M; Martinez-Lorente A; Llombart-Bosch A
Anticancer Res; 1998; 18(1B):677-82. PubMed ID: 9584051
[TBL] [Abstract][Full Text] [Related]
19. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
